Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rxsight Inc (NQ: RXST )

61.15 +0.56 (+0.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 309,541
Open 60.85
Bid (Size) 60.69 (1)
Ask (Size) 61.63 (1)
Prev. Close 60.59
Today's Range 60.27 - 62.88
52wk Range 20.66 - 66.54
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Do You Have Your Eye On Vision Care Stocks?
For investors seeking stable and growing opportunities, eye care stocks are an attractive option. 
Via Talk Markets
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RxSight, Inc.
Via GlobeNewswire

Performance

YTD
+66.85%
+66.85%
1 Month
+15.73%
+15.73%
3 Month
+11.81%
+11.81%
6 Month
+108.21%
+108.21%
1 Year
+139.24%
+139.24%

More News

Read More
Why RxSight (RXST) Shares Are Falling
Via Benzinga
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
What 10 Analyst Ratings Have To Say About RxSight
Via Benzinga
Assessing RxSight: Insights From 8 Financial Analysts
Via Benzinga
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RxSight, Inc. Reports First Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Forecasting The Future: 9 Analyst Projections For RxSight
Via Benzinga
Recap: RxSight Q4 Earnings
Via Benzinga
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
RxSight's Earnings Outlook
Via Benzinga
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
Via Benzinga
The Analyst Landscape: 8 Takes On RxSight
Via Benzinga
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
Chart Of The Day: RxSight - Cashing In On Cataracts
Via Talk Markets
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Earnings Scheduled For February 28, 2024
Via Benzinga
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From RxSight, Inc.
Via GlobeNewswire
Insiders are selling these hot stocks on track for higher prices
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.